ACKB Ackermans & van Haaren NV

Ackermans & van Haaren: Annual results 2018

Ackermans & van Haaren: Annual results 2018

“Ackermans & van Haaren fully focussed on the further expansion of its core sectors in 2018. The fact that the resulting contribution of these participations has increased by 35.4 million euros (+13%), to a record level of 312.4 million euros, is satisfactory to us.



We have made strategic choices within the portfolio throughout the year, and have sold our participations in Atenor, BDM-Asco and Distriplus. This has freed up people and resources for new initiatives aiming at sustainable growth of Ackermans & van Haaren, both within the current portfolio as through new investments, such as the recently announced new participation in Biolectric.“



Jan Suykens, CEO - Chairman of the executive committee



You can read our press release about the annual results via the link below, or watch the video message of Jan Suykens, CEO of Ackermans & van Haaren, later this morning on our website:







Attachment

EN
28/02/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ackermans & van Haaren NV

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Ackermans & van Haaren: Results capping already strong subsidiary reporting. DPS beat. Fagron: Acquisition of Pharmavit Europe, active in nutraceutical raw materials. Fugro: Patience please. Kendrion: Sees signs of improvement in EU economy. Proximus: 2026 dividend halved, 2028-30 targets a bit better on lower capex. Proximus: 4Q25 in line EBITDA on weaker sales, FCF up; 2026 guidance below on EBITDA. Recticel: Strong FY25 results, CEO transition seen as a negative

Guy Sips ... (+7)
  • Guy Sips
  • Hilde Van Boxstael
  • Livio Luyten
  • Mathijs Geerts Danau
  • Michiel Declercq
  • Wim Hoste
  • Wim Lewi

Morning Notes : ACKB BB, FAGR BB, FUR NA, MTLS US, MDXH BB, PROX BB, R...

: ACKB BB, FAGR BB, FUR NA, MTLS US, MDXH BB, PROX BB, RECT BB, WHATS BB

ResearchPool Subscriptions

Get the most out of your insights

Get in touch